Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!


Therapeutic Approach

Infantile hemangiomas are common, benign tumors of infancy. They follow a predictable pattern of rapid proliferation during the first several months of life, cessation of growth typically by 12 months of age, and then slow involution for a variable number of years thereafter. Many infantile hemangiomas require no treatment given they are benign and tend to self-resolve; however, treatment is appropriate in certain clinical scenarios. Problematic infantile hemangiomas are those that may result in functional impairment due to location, permanent scarring in cosmetically sensitive areas, ulceration, and discomfort, or cause life-threatening complications (eg, airway, hepatic hemangiomas). Both pharmacologic and procedural interventions can be utilized, and therapeutic selection is based on myriad factors including the lesion location, clinical subtype, size, depth (superficial vs deep), ulceration, and potential for scarring/permanent skin changes. See Table 110-1.

Table 110-1Infantile Hemangioma Treatment Table

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.